Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Suda, N. Tanabe, F. Kato, H. Kasai, T. Takeuchi, T. Urushibara, A. Sekine, R. Nishimura, T. Jujo, T. Sugiura, A. Shigeta, S. Sakao, Y. Kasahara, K. Tatsumi (Chiba, Japan). Diffusing capacity for carbon monoxide and mortality in patients with chronic thromboembolic pulmonary hypertension. Eur Respir J 2012; 40: Suppl. 56, 3896

Member's Comments

No comment yet.

Related content which might interest you: Carbon monoxide diffusing capacity and the complexity of diagnosis in pulmonary arterial hypertension Source: Eur Respir J 2014; 43: 963-965 Year: 2014 Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 268s Year: 2005 Nitrogen dioxide increases the risk of mortality in idiopathic pulmonary fibrosis Source: Eur Respir J, 57 (5) 2001877; 10.1183/13993003.01877-2020 Year: 2021 Diffusing capacity for carbon monoxide (DLco) may predict appearance of pulmonary hypertension in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 The diagnostic value of exhaled carbon monoxide and arterial carboxyhaemoglobin measurements in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 408s Year: 2006 Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study Source: Eur Respir J 2007; 30: 1131-1137 Year: 2007 Relationship between diffusing capacity for carbon monoxide and severity of airway obstruction, presence of cor pulmonale chronic in obese and nonobese stable COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 726s Year: 2006 Clinical usefulness of end-tidal CO2 profiles during rapidly-incremental exercise in patients with idiopathic and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2013 –Clinical exercise physiology Year: 2013 Carbon monoxide diffusing capacity (DLCO) in COVID-19 survivors versus idiopathic pulmonary fibrosis (IPF): the pathogenetic features Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases Year: 2021 More on idiopathic pulmonary arterial hypertension with a low diffusing capacity Source: Eur Respir J, 50 (2) 1700354; 10.1183/13993003.00354-2017 Year: 2017 Slope of exercise ventilation to carbon dioxide production in patients with pulmonary arterial hypertension, either primary or associated with connective tissue disease Source: Annual Congress 2008 - Pulmonary mechanics and gas exchange Year: 2008 No effect of baseline diffusing capacity of lung for carbon monoxide on benefit of nintedanib Source: International Congress 2016 – IPF treatment II Year: 2016 Ventilatory inefficiency relative to oxygen uptake and carbon dioxide output are independent predictors of mortality in pulmonary arterial hypertension Source: Annual Congress 2013 –Respiratory physiology in health and disease Year: 2013 Mechanisms of exertional dyspnea in patients with mild COPD and low resting lung diffusing capacity for carbon monoxide (DLCO) Source: Virtual Congress 2020 – Exploring exercise responses in respiratory diseases Year: 2020 Pulmonary veno-occlusive disease Source: Eur Respir J 2009; 33: 189-200 Year: 2009 Diffusing capacity and lung circulation in chronic obstructive pulmonary disease with different degrees of respiratory failure Source: Eur Respir J 2001; 18: Suppl. 33, 251s Year: 2001 Change in diffusing capacity for carbon monoxide as a predictor of outcomes in connective tissue disease-associated pulmonary arterial hypertension: Analysis from the REVEAL registry Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012 Pulmonary hypertension and exercise capacity in patients with severe chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 285s Year: 2002 Noninvasive positive pressure ventilation using helium:oxygen versus air:oxygen in acute respiratory failure in chronic obstructive pulmonary disease patients exposed to sulfur mustard Source: Annual Congress 2008 - Use of noninvasive ventilation in various conditions Year: 2008 The role of spirometry and ?arbon monoxide diffusing capacity (DLCO) in the diagnosis of pulmonary function in patients after COVID-19 pneumonia Source: Virtual Congress 2021 – Pulmonary rehabilitation in the COVID-19 era Year: 2021